Jon Congleton - Chief Executive Officer, Director at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
MLYS on Nasdaq
All Insider Reports
All Insider Reports

Jon Congleton - trading volume in the past year for Mineralys Therapeutics, Inc.

Holdings reported by Jon Congleton for Mineralys Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 780,051 $26,740,148 $34.28 19 Feb 2026 Direct
Stock Option 187,900 19 Feb 2026 Direct Common Stock

Transactions reported by Jon Congleton for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.